132 related articles for article (PubMed ID: 12610520)
21. Interleukin 2-mediated uncoupling of T cell receptor alpha/beta from CD3 signaling.
Haughn L; Leung B; Boise L; Veillette A; Thompson C; Julius M
J Exp Med; 1998 Nov; 188(9):1575-86. PubMed ID: 9802969
[TBL] [Abstract][Full Text] [Related]
22. Lck is required for activation-induced T cell death after TCR ligation with partial agonists.
Yu XZ; Levin SD; Madrenas J; Anasetti C
J Immunol; 2004 Feb; 172(3):1437-43. PubMed ID: 14734719
[TBL] [Abstract][Full Text] [Related]
23. Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy.
Rabinowich H; Banks M; Reichert TE; Logan TF; Kirkwood JM; Whiteside TL
Clin Cancer Res; 1996 Aug; 2(8):1263-74. PubMed ID: 9816296
[TBL] [Abstract][Full Text] [Related]
24. CD3 hyporesponsiveness and in vitro apoptosis are features of T cells from both malignant and nonmalignant secondary lymphoid organs.
Agrawal S; Marquet J; Delfau-Larue MH; Copie-Bergman C; Jouault H; Reyes F; Bensussan A; Farcet JP
J Clin Invest; 1998 Nov; 102(9):1715-23. PubMed ID: 9802885
[TBL] [Abstract][Full Text] [Related]
25. Tumor-infiltrating CD3- NK cells are more effective than CD3+ T cells in killing autologous melanoma cells.
Azogui O; Avril MF; Margulis A; Guillard M; Caillou B; Prade M
J Invest Dermatol; 1991 Sep; 97(3):425-9. PubMed ID: 1831465
[TBL] [Abstract][Full Text] [Related]
26. Defining the roles of perforin, Fas/FasL, and tumour necrosis factor alpha in T cell induced mucosal damage in the mouse intestine.
Merger M; Viney JL; Borojevic R; Steele-Norwood D; Zhou P; Clark DA; Riddell R; Maric R; Podack ER; Croitoru K
Gut; 2002 Aug; 51(2):155-63. PubMed ID: 12117872
[TBL] [Abstract][Full Text] [Related]
27. Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures.
Frost PJ; Butterfield LH; Dissette VB; Economou JS; Bonavida B
J Immunol; 2001 Mar; 166(5):3564-73. PubMed ID: 11207317
[TBL] [Abstract][Full Text] [Related]
28. Blockade of the Fas-triggered intracellular signaling pathway in human melanomas is circumvented by cytotoxic lymphocytes.
Ferrarini M; Imro MA; Sciorati C; Heltai S; Protti MP; Pellicciari C; Rovere P; Manfredi AA; Rugarli C
Int J Cancer; 1999 May; 81(4):573-9. PubMed ID: 10225447
[TBL] [Abstract][Full Text] [Related]
29. CD8(+) tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis.
Radoja S; Saio M; Schaer D; Koneru M; Vukmanovic S; Frey AB
J Immunol; 2001 Nov; 167(9):5042-51. PubMed ID: 11673513
[TBL] [Abstract][Full Text] [Related]
30. Apoptosis in acute shigellosis is associated with increased production of Fas/Fas ligand, perforin, caspase-1, and caspase-3 but reduced production of Bcl-2 and interleukin-2.
Raqib R; Ekberg C; Sharkar P; Bardhan PK; Zychlinsky A; Sansonetti PJ; Andersson J
Infect Immun; 2002 Jun; 70(6):3199-207. PubMed ID: 12011015
[TBL] [Abstract][Full Text] [Related]
31. Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.
Itoh K; Platsoucas CD; Balch CM
J Exp Med; 1988 Oct; 168(4):1419-41. PubMed ID: 3262710
[TBL] [Abstract][Full Text] [Related]
32. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
Elsässer-Beile U; Gierschner D; Welchner T; Wetterauer U
Anticancer Res; 2003; 23(1A):433-7. PubMed ID: 12680244
[TBL] [Abstract][Full Text] [Related]
33. Interleukin 2 restores CD3-zeta chain expression but fails to generate tumour-specific lytic activity in tumour-infiltrating lymphocytes derived from human colorectal hepatic metastases.
Yoong KF; Adams DH
Br J Cancer; 1998 Apr; 77(7):1072-81. PubMed ID: 9569042
[TBL] [Abstract][Full Text] [Related]
34. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant adoptive immunotherapy with tumour-infiltrating lymphocytes and modulated doses of interleukin-2 in 22 patients with melanoma, colorectal and renal cancer, after radical metastasectomy, and in 12 advanced patients.
Ridolfi R; Flamini E; Riccobon A; De Paola F; Maltoni R; Gardini A; Ridolfi L; Medri L; Poletti G; Amadori D
Cancer Immunol Immunother; 1998 Jun; 46(4):185-93. PubMed ID: 9671141
[TBL] [Abstract][Full Text] [Related]
36. Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis.
Okada K; Komuta K; Hashimoto S; Matsuzaki S; Kanematsu T; Koji T
Clin Cancer Res; 2000 Sep; 6(9):3560-4. PubMed ID: 10999744
[TBL] [Abstract][Full Text] [Related]
37. Proliferative, phenotypic and functional and molecular characteristics of tumour-infiltrating lymphocytes obtained from unselected patients with malignant melanomas and expanded in vitro in the presence of recombinant interleukin-2.
Melioli G; Guastella M; Semino C; Meta M; Pietra G; Ponte M; Queirolo P; Sertoli MR; Martini L; Reali UM
Melanoma Res; 1994 Apr; 4(2):127-33. PubMed ID: 8069098
[TBL] [Abstract][Full Text] [Related]
38. T cell receptor-zeta and granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma.
Mulder WM; Bloemena E; Stukart MJ; Kummer JA; Wagstaff J; Scheper RJ
Gut; 1997 Jan; 40(1):113-9. PubMed ID: 9155587
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Fas- versus perforin-mediated pathways of cytotoxicity in TCR- and Thy-1-activated murine T cells.
Kojima H; Toda M; Sitkovsky MV
Int Immunol; 2000 Mar; 12(3):365-74. PubMed ID: 10700471
[TBL] [Abstract][Full Text] [Related]
40. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]